Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02244-y
Abstract: To the editor In-hospital patients with severe acute respiratory syndrome coronavirus 2-induced disease (COVID-19) have a high risk of thrombosis [1–4]. Pharmacological thromboprophylaxis is strongly encouraged, and several experts even suggest the use of high-dose… read more here.
Keywords: receiving intensive; prevalence covid; covid; patients covid ... See more keywords
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0706
Abstract: Aim: This retrospective, observational study assessed healthcare resource utilization (HCRU) and costs for newly diagnosed acute myeloid leukemia (AML) patients receiving intensive induction chemotherapy. Materials & methods: Adult AML patients with inpatient hospitalization or hospital-based outpatient… read more here.
Keywords: induction chemotherapy; receiving intensive; newly diagnosed; intensive induction ... See more keywords